Showing results (221-230 of 636) with videos related to
Sort By:
Pageof 64
The Clinical Investigator|January 1, 1994
The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growthF Jockenhövel, S Lederbogen, T Olbricht, et al.Nederlands Tijdschrift Voor Geneeskunde|July 22, 1989
[The effect of immunoscintigraphy with monoclonal antibodies on assays of hormones and tumor markers. This is not the end of the matter!]J A Janssen, P J Blankestijn, R Docter, et al.The Journal of Clinical Endocrinology and Metabolism|January 1, 1990
Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal glandS W Lamberts, J Zuiderwijk, P Uitterlinden, et al.The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Somatostatin modulates G-CSF-induced but not interleukin-3-induced proliferative responses in myeloid 32D cells via activation of somatostatin receptor subtype 2S P Oomen, A C Ward, L J Hofland, et al.Endocrinology|September 1, 1995
Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotideL J Hofland, P M van Koetsveld, M Waaijers, et al.European Journal of Endocrinology|August 1, 1995
Octreotide, but not bromocriptine, increases circulating insulin-like growth factor binding protein 1 levels in acromegalyW W de Herder, P Uitterlinden, A J van der Lely, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1989
Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormoneL J Hofland, P M van Koetsveld, C C van Vroonhoven, et al.Pacing and Clinical Electrophysiology : PACE|November 1, 1989
Undersensing of P waves in the presence of an adequate P wave due to automatic postventricular atrial refractory period extensionJ H Wilson, S LattnerJournal of Psychosocial Nursing and Mental Health Services|February 1, 1995
Therapeutic partnership. A model for clinical practiceJ H Wilson, H HobbsPacing and Clinical Electrophysiology : PACE|October 1, 1988
Apparent undersensing due to oversensing of low amplitude pulses in a thoracic impedance-sensing, rate-responsive pacemakerJ H Wilson, S LattnerPageof 64